Cited by 436Genetics and Neurodevelopmental DisordersGenomics and Rare DiseasesSexual Differentiation and Disorders

Incidence of Fragile X Syndrome by Newborn Screening for Methylated FMR1 DNA

Open access
Coffee, Bradford, Keith, Krayton, Albizua, Igor, Malone, Tamika, Mowrey, Julie, Sherman, Stephanie L., Warren, Stephen T.·2009·The American Journal of Human Genetics

Abstract

Fragile X syndrome (FXS) results from a CGG-repeat expansion that triggers hypermethylation and silencing of the FMR1 gene. FXS is referred to as the most common form of inherited intellectual disability, yet its true incidence has never been measured directly by large population screening. Here, we developed an inexpensive and high-throughput assay to quantitatively assess FMR1 methylation in DNA isolated from the dried blood spots of 36,124 deidentified newborn males. This assay displays 100% specificity and 100% sensitivity for detecting FMR1 methylation, successfully distinguishing normal males from males with full-mutation FXS. Furthermore, the assay can detect excess FMR1 methylation in 82% of females with full mutations, although the methylation did not correlate with intellectual disability. With amelogenin PCR used for detecting the presence of a Y chromosome, this assay can also detect males with Klinefelter syndrome (KS) (47, XXY). We identified 64 males with FMR1 methylation and, after confirmatory testing, found seven to have full-mutation FXS and 57 to have KS. Because the precise incidence of KS is known, we used our observed KS incidence as a sentinel to assess ascertainment quality and showed that our KS incidence of 1 in 633 newborn males was not significantly different from the literature incidence of 1 in 576 (p = 0.79). The seven FXS males revealed an FXS incidence in males of 1 in 5161 (95% confidence interval of 1 in 10,653-1 in 2500), consistent with some earlier indirect estimates. Given the trials now underway for possible FXS treatments, this method could be used in newborn or infant screening as a way of ensuring early interventions for FXS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ajhg.2009.09.007

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Coffee, B., Keith, K., Albizua, I., Malone, T., Mowrey, J., Sherman, S. L., & Warren, S. T.
Affiliations
Emory University (US)
Corresponding author
Warren, Stephen T.
Venue
The American Journal of Human Genetics
Publisher
Elsevier BV
Published
2009-10
Volume
85
Issue
4
Pages
503-514
ISSN
0002-9297 (ISSN-L)
OpenAlex
W2106750209
Cited by
436
References
52
Citations by year
2026: 5 · 2025: 11 · 2024: 20 · 2023: 16 · 2022: 19 · 2021: 21 · 2020: 26 · 2019: 24 · 2018: 26 · 2017: 41 · 2016: 31 · 2015: 29 · 2014: 35 · 2013: 36 · 2012: 24
FWCI
18.61
Type
journal article
Language
en
Open access
Locations
  • The American Journal of Human Genetics (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Association of American Medical Colleges
  • National Institutes of Health (HD024064)
  • Centers for Disease Control and Prevention
  • U.S. Public Health Service (MM-0937-06/06)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 024064, HD020521, R01HD020521, P30HD024064, R37HD020521)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
Keywords
fragile X syndrome, FMR1 gene, CGG repeat expansion, DNA methylation, newborn screening, incidence, Klinefelter syndrome, dried blood spots, intellectual disability, FMR1 full mutation
MeSH terms
Base Sequence, DNA, DNA Mutational Analysis, Fragile X Syndrome, Humans, Infant, Newborn, Klinefelter Syndrome, Male, Molecular Sequence Data, Promoter Regions, Genetic, Sensitivity and Specificity, Sequence Homology, Nucleic Acid, Neonatal Screening, DNA Primers, DNA Methylation, Fragile X Messenger Ribonucleoprotein 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review